NCT04633551View on ClinicalTrials.gov

Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

May 30, 2022

Conditions
Pre-EclampsiaPre-TermIntrauterine Growth RestrictionHypertension in Pregnancy
Interventions
DIETARY_SUPPLEMENT

Anti-inflammatory supplement

commercially available combination of curcumin, quercitin, resveratrol, and green tea

Trial Locations (1)

29208

Public Health Research Center, Columbia

All Listed Sponsors
lead

University of South Carolina

OTHER

NCT04633551 - Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes | Biotech Hunter | Biotech Hunter